Evaluating the Effectiveness of AIT in the Treatment of Pain Related to Pancreatic Cancer
Clinique Bizet · Pancreatic Cancer Pain · Intrathecal Analgesic
Not applicable
Not yet recruiting
40
2026-07
Evidence dashboardStudies since 2001Updated Jul 31, 2026
ZiconotideClinical Trials.
A source-linked view of every Ziconotide study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.
- Total trials
- 14
- Recruiting
- 2
- Completed
- 7
- Terminated
- 0
- Results posted
- 1
- Average enrollment
- 84
- Countries
- 6
- Highest phase
- Phase 4
Largest indexed study
300 participants · NCT04321408 →Developer / research origin
Jazz Pharmaceuticals
Evidence summary
Activity is not efficacy.
Ziconotide appears in 14 indexed studies: 2 recruiting, 7 completed and 1 with registry results posted. The highest registered development stage in this snapshot is Phase 4. These counts measure registry activity; they do not establish that Ziconotide is safe or effective.
Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.
Current studies
Recruiting or active
Completed studies
Finished records
Stopped studies
Withdrawn or terminated
NCT IDStudyPhase / statusEnrollmentUpdated
Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy
Christian Hospital Northeast Northwest · Chemotherapy Induced Peripheral Neuropathy (CIPN)
Not applicable
Not yet recruiting
24
2026-03
OP2C : Prialt® Observatory in Clinical Practice
Institut Cancerologie de l'Ouest · Refractory Pain
Not applicable
Recruiting
300
2025-08
Ziconotide for Non-cancer Pain by Intrathecal Administration
ESTEVE Pharmaceuticals SAS · Pain, Chronic
Not applicable
Recruiting
85
2025-02
NCT IDStudyPhase / statusEnrollmentUpdated
Ziconotide as First-Line IDT
Albany Medical College · Neuropathic Pain
Phase 4
Completed
13
2021-01
Patient Registry of Intrathecal Pain Management in Europe for Prialt (Ziconotide Intrathecal Infusion) and Alternative Drugs for the Management of Severe, Chronic Pain.
Eisai Limited · Pain Management · Severe Chronic Pain
Not applicable
Completed
219
2018-10
Patient Registry of Intrathecal Ziconotide Management(PRIZM)
Jazz Pharmaceuticals · Patients With Severe Chronic Pain
Not applicable
Completed
93
2017-03
Prialt (Ziconotide) In Severe Chronic Pain
Elan Pharmaceuticals · Pain
Phase 3
Completed
220
2015-12
Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
Elan Pharmaceuticals · Pain
Phase 3
Completed
300
2015-12
Intrathecal Bolus Doses of Ziconotide
University Hospital, Linkoeping · Peripheral Neuropathy
Phase 4
Completed
26
2014-12
Showing 6 of 7 studies
NCT IDStudyPhase / statusEnrollmentUpdated
Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy
Aaron Boster · Painful Myelopathy · Painful Neuropathy
Phase 4
Withdrawn
0
2018-09
Full study index
Search Ziconotide trials.
Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.
14 matching studies
Last registry update first
Latest publications
Follow the paper trail.
PMID 35183448 ↗Park J, Park EY, Han SS, Park HM, Lee M, Lee SA, Kim SW, Kim DH, Park SJ. Randomized controlled study comparing the analgesic effects of intravenous patient-controlled analgesia and patient-controlled epidural analgesia after open major surgery for pancreatobiliary cancer. HPB (Oxford). 2022 Aug;24(8):1238-1244. doi: 10.1016/j.hpb.2022.01.013. Epub 2022 Feb 3.Linked from NCT07733427PMID 28025375 ↗Bruel BM, Burton AW. Intrathecal Therapy for Cancer-Related Pain. Pain Med. 2016 Dec;17(12):2404-2421. doi: 10.1093/pm/pnw060. Epub 2016 Apr 28.Linked from NCT07733427PMID 18054150 ↗Cohen SP, Dragovich A. Intrathecal analgesia. Anesthesiol Clin. 2007 Dec;25(4):863-82, viii. doi: 10.1016/j.anclin.2007.07.001.Linked from NCT07733427PMID 18443642 ↗Smith HS, Deer TR, Staats PS, Singh V, Sehgal N, Cordner H. Intrathecal drug delivery. Pain Physician. 2008 Mar;11(2 Suppl):S89-S104.Linked from NCT07733427PMID 25638694 ↗Rizvi S, Kumar K. History and present state of targeted intrathecal drug delivery. Curr Pain Headache Rep. 2015;19(2):474. doi: 10.1007/s11916-014-0474-8.Linked from NCT07733427PMID 10642496 ↗Haan S, Kortylewski M, Behrmann I, Muller-Esterl W, Heinrich PC, Schaper F. Cytoplasmic STAT proteins associate prior to activation. Biochem J. 2000 Feb 1;345 Pt 3(Pt 3):417-21.Linked from NCT07733427PMID 29543644 ↗Carvajal G, Dupoiron D, Seegers V, Lebrec N, Bore F, Dubois PY, Leblanc D, Delorme T, Jubier-Hamon S. Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center. Anesth Analg. 2018 Jun;126(6):2038-2046. doi: 10.1213/ANE.0000000000002903.Linked from NCT07733427PMID 14612485 ↗Bruera E, Kim HN. Cancer pain. JAMA. 2003 Nov 12;290(18):2476-9. doi: 10.1001/jama.290.18.2476. No abstract available.Linked from NCT07733427
Related pages
Keep researching Ziconotide.
Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.